Prefilled Syringes Market Estimated to Witness High Growth Owing to Greater Adoption and Technological Advancements

Market Overview:
Prefilled syringes are disposable, sterile syringes that are filled with a ready-to-administer, liquid formulation of a drug. They are commonly used for vaccination and dosing of biologics and other injectable drugs. The rising cases of chronic diseases, technological advancements in product design and ease of administration are driving greater adoption of prefilled syringes across the pharmaceutical and healthcare industries.

Market Dynamics:
Rising incidence of chronic diseases such as cancer, diabetes and autoimmune disorders is expected to drive the demand for prefilled syringes during the forecast period. According to WHO, cancer is the second leading cause of death globally and accounted for nearly 10 million deaths in 2020. Similarly, the International Diabetes Federation estimates that approximately 537 million adults were living with diabetes in 2021 globally. The adoption of prefilled syringes minimizes dosage errors and reduces production time and costs for drug manufacturers compared to vials. Furthermore, technological developments such as integrated safety systems and track-and-trace codification are making prefilled syringes more user-friendly and contributing to their increased preference over conventional vials and syringes. However, stringent regulations pertaining to development and production of prefilled syringes may negatively impact market growth.

Segment Analysis
The global prefilled syringes market is segmented based on material, type, disease indication and therapeutics area. Glass prefilled syringes dominates the material segment due to ease of use and ability to withstand high pressure and autoclaving. Among types, conventional prefilled syringes leads owing to higher usage in routine immunization and vaccination programs. By disease indication, autoimmune disorders records lucrative growth on account of rising prevalence of conditions like arthritis and diabetes. The therapeutics segment is led by monoclonal antibodies owing to expanding applications in oncology and metabolic disorders.

PEST Analysis
Political: Streamlined regulatory approvals and favorable policy support for development and adoption of injectable drug delivery systems spur market growth.
Economic: Rising healthcare spending for management of chronic illnesses along with growth in generic drug market creates new opportunities.
Social: Increasing patient awareness about benefits of prefilled syringes like convenience, safety and accurate drug dosing augment their demand.
Technological: Advancements in material sciences, connectivity features and customization capabilities extend functionality and drive preference over traditional vials and syringes.

Key Takeaways

The Global Prefilled Syringes Market is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing demand for self-administered injectables and rising prevalence of chronic diseases.
Regional analysis indicates North America captures over 40% share supported by well-established healthcare system and large patient pool requiring biologics. Asia Pacific is anticipated to witness fastest growth backed by expanding pharmaceutical manufacturing industry and growing medical tourism.

Regional analysis related content comprises
Asia Pacific market for prefilled syringes is expected to witness fastest growth during the forecast period. This can be attributed to factors such as rising healthcare spending, developing pharmaceutical manufacturing sector, increasing frequency of diseases and growing awareness among population regarding benefits of self-injection. China and India lead the Asia Pacific market owing to presence of huge patient base, cost effective generics manufacturing and growing adoption of advanced parenteral drug delivery systems.

Key players related content comprises
Key players operating in the prefilled syringes market are Gerresheimer AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, Stevanato Group S.p.A. Some of the leading manufacturers are focused on expanding capacity and product portfolio through strategic collaborations to strengthen market position.

Read More:

Leave a Comment